Peer Review reports

From: Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

Original Submission
1 Jun 2007	Submitted	Original manuscript
	Author responded	Author comments
	Reviewed	Reviewer Report
	Reviewed	Reviewer Report
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
	Author responded	Author comments
	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
15 Nov 2007	Editorially accepted
15 Nov 2007	Article published	10.1186/1741-7015-5-33

You can find further information about peer review here.

Back to article page